The treatment significantly reversed insulin resistance and hypertriglyceridemia, improved carbohydrate homeostasis, and promoted the redistribution of adipose tissue towards a more favorable phenotype by inducing adipocyte hyperplasia and increasing adiponectin levels. Here, ADIPOQ is linked to hypertriglyceridemia.